Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0000950123-10-079088
Filing Date
2010-08-19
Accepted
2010-08-19 13:52:05
Documents
16

Document Format Files

Seq Description Document Type Size
1 425 w79613e8vk.htm 425 13781
2 EX-99.1 w79613exv99w1.htm EX-99.1 12724
3 GRAPHIC w79613w79613z0001.gif GRAPHIC 26209
4 GRAPHIC w79613w79613z0002.gif GRAPHIC 82444
5 GRAPHIC w79613w79613z0003.gif GRAPHIC 42387
6 GRAPHIC w79613w79613z0004.gif GRAPHIC 44134
7 GRAPHIC w79613w79613z0005.gif GRAPHIC 66732
8 GRAPHIC w79613w79613z0006.gif GRAPHIC 52167
9 GRAPHIC w79613w79613z0007.gif GRAPHIC 23745
10 GRAPHIC w79613w79613z0008.gif GRAPHIC 41680
11 GRAPHIC w79613w79613z0009.gif GRAPHIC 72254
12 GRAPHIC w79613w79613z0010.gif GRAPHIC 40629
13 GRAPHIC w79613w79613z0011.gif GRAPHIC 98705
14 GRAPHIC w79613w79613z0012.gif GRAPHIC 63939
15 GRAPHIC w79613w79613z0013.gif GRAPHIC 33583
16 GRAPHIC w79613w79613z0014.gif GRAPHIC 26209
  Complete submission text file 0000950123-10-079088.txt   1015540
Mailing Address 2401 4TH AVENUE SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVENUE SUITE 1050 SEATTLE WA 98121 2068380500
Trubion Pharmaceuticals, Inc (Subject) CIK: 0001298521 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-33054 | Film No.: 101027556
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filed by) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations